Abstract:Contaminations by pharmaceuticals, personal care products, and other emerging pollutants in water resources have become a seriously burgeoning issue of global concern in the first third of the twenty-first century. As societal reliance on pharmaceuticals continues to escalate, the inadvertent introduction of these substances into water reservoirs poses a consequential environmental threat. Therefore, the aim of this study was to investigate reductive degradation, particularly, catalytic hydrogenation regarding model pollutants such as diclofenac (DCF), ibuprofen (IBP), 17α-ethinylestradiol (EE2), or bisphenol-A (BPA), respectively, in aqueous solutions at lab scale. Iron bimetals (zero valent iron, ZVI, and copper, Cu, or nickel, Ni) as well as zero valent magnesium (Mg, ZVM) in combination with rhodium, Rh, or palladium, Pd, as hydrogenation catalysts (HK), were investigated. Studies were executed through various short-term batch experiments, with multiple sample collections, over a total range of 120 min. The results indicated that DCF was attenuated at over 90 % when exposed to Fe-Cu or a Fe-Ni bimetal (applied as a single model pollutant). However, when DCF was part of a mixture alongside with IBP, EE2, and BPA, the attenuation efficacy decreased to 79 % with Fe-Cu and 23 % with Fe-Ni. Conversely, both IBP and BPA exhibit notably low attenuation levels with both bimetals, less than 50 %, both deployed as single substances or in mixtures. No reaction (degradation) products could be identified employing LC-MS, but sometimes a release of the parent pollutant when applying an acetic acid buffer could be noted to a certain extent, suggesting adsorption processes on corrosion products such as iron hydroxide and/or oxides. Surprisingly, Mg in combination with Rh (Rh-HK) or Pd (Pd-HK) showed a significantly rapid decrease in the concentrations of DCF, EE2, and BPA, in part up to approximately 100 %, that is, within a few minutes only in part due to hydrogenation degradation reactions (related reaction products could actually be identified by LC-MS; adsorption processes were not observed here). Moreover, kinetic modeling of the DCF degradation with Mg-Rh-HK was conducted at different temperatures (15 °C, 20 °C, 25 °C, 35 °C) and varied initial concentrations (2.5 mg/L, 5.0 mg/L, 7.5 mg/L, 10.0 mg/L). The outcomes prove that the degradation of DCF at the Rh-HK's surface followed a modified first-order kinetics, most probably by catalytic hydrodehalogenation and subsequent hydrogenation of the aromatic moieties (molecular hydrogen was provided by the corrosion of Mg). From the determined reaction rate constants at four different temperatures, the activation energy was estimated to be 59.6 kJ/mol by means of the Arrhenius equation what is in good agreement with similar results reported in the literature. This coupled hydrodehalogenation and hydrogenation approach may be upscaled into a new promising technical process for comprehensively removing such pharmaceuticals and similar pollutants in sewage plants in a single step, furthermore, even in combination with adsorption by activated carbon and/or ozonation which have already been established at some sewage plants in Switzerland and Germany recently.

Insights into catalyst-free, highly effective degradation of pharmaceutical contaminant in aqueous solution by a dielectric barrier discharge system

Dielectric Barrier Discharge Induced Degradation of Diclofenac in Aqueous Solution

Mechanism and Reactive Species in a Fountain-Strip DBD Plasma for Degrading Perfluorooctanoic Acid (PFOA)

An Energy Efficient Process for Degrading Perfluorooctanoic Acid (PFOA) Using Strip Fountain Dielectric Barrier Discharge Plasma

DIELECTRIC BARRIER DISCHARGE INDUCED DEGRADATION OF DICLOFENAC SODIUM IN AQUEOUS SOLUTION

Rapid Degradation of Carbamazepine in Wastewater Using Dielectric Barrier Discharge-Assisted Fe3+/Sodium Sulfite Oxidation

Degradation of Pharmaceutical Contaminant Tetracycline in Aqueous Solution by Coaxial-Type DBD Plasma Reactor

Plasma-microbubble treatment and sustainable agriculture application of diclofenac-contaminated wastewater

The enhancing energy efficiency of sulfadiazine degradation using a DBD-contact plasma treatment process

Electrochemical degradation of DCF by boron-doped diamond anode: degradation mechanism, pathways and influencing factors

Enhanced synergistic performance of nano-Fe0-CeO2 composites for the degradation of diclofenac in DBD plasma

Degradation of tetracycline hydrochloride in aqueous via combined dielectric barrier discharge plasma and Fe–Mn doped AC

Degradation of Diclofenac in Water Using the O3/UV/S2O8 Advanced Oxidation Process

Plasma-catalytic degradation of ciprofloxacin in aqueous solution over different MnO2 nanocrystals in a dielectric barrier discharge system

Degradation of Diclofenac in Water Using S2O82−/Fe2O3-zeolite Catalyst Synergistic with Ozone

Removal of Pharmaceutical Residues from Water and Wastewater Using Dielectric Barrier Discharge Methods—A Review

Efficient degradation of diclofenac by digestate-derived biochar catalyzed peroxymonosulfate oxidation: Performance, machine learning prediction, and mechanism

Insights into water film DBD plasma driven by pulse power for ibuprofen elimination in water: performance, mechanism and degradation route

Evaluation of diclofenac degradation effect in “active” and “non-active” anodes: A new consideration about mineralization inclination

Degradation of pharmaceuticals and other emerging pollutants employing bi-metal catalysts/magnesium and/or (green) hydrogen in aqueous solution

Biotransformation of diclofenac by isolated super-degrader Pseudomonas sp. DCα4: Postulated pathways, and attenuated ecotoxicological effects